Selective Inhibition of COX-2 by a Standardized CO₂ Extract of Humulus lupulus in vitro and its Activity in a Mouse Model of Zymosan-Induced Arthritis

Abstract

A standardized CO₂ extract from Humulus lupulus L. (hop extract) was investigated for its selective COX-1/2 inhibitory properties. An in vitro model of inflammation using lipopolysaccharide (LPS)-stimulated human peripheral blood mononuclear cells (PBMC) was used as a model to investigate the effect of hop extract on PGE₂ production. COX-1/2 selective inhibition by the hop extract was investigated in a COX-1 whole blood assay (WBA) and a COX-2 WBA. To evaluate the in vivo activity of hop extract, it was administered orally to C57BL/6 mice in which inflammation of the right joint was induced by injecting zymosan intra-articularly. Ex vivo PGE₂ production of LPS-stimulated blood cells was determined. Also, the effect of hop extract on healthy and arthritic cartilage was investigated as well as effects on inflammatory joint swelling. Hop extract inhibited PGE₂ production by LPS-stimulated PBMC without compromising the metabolic activity of these cells. Furthermore, hop extract showed a decline in PGE₂ production in the COX-2 whole blood assay (WBA) with an IC₅₀ of 20.4 μg/mL, while in the COX-1 WBA no inhibition of PGE₂ production was observed. This indicates a COX-2 selective inhibition. The COX-1 inhibitor SC-560 inhibited PGE₂ production in the COX-1 WBA but not in the COX-2 WBA. At 2 μM, celecoxib inhibited PGE₂ production in the COX-2 WBA by 92 % and in the COX-1 WBA by 50 %. When hop extract was administered orally to C57BL/6 mice in which joint inflammation was induced with zymosan, PGE₂ production in ex vivo LPS-stimulated whole blood was significantly decreased by 24 %, suggesting that hop extract becomes bioavailable. Furthermore, oral administration of hop extract showed no negative or positive effects on healthy cartilage proteoglycan synthesis, or on zymosan-induced arthritic cartilage proteoglycan synthesis. However, no effect of oral administration of 1.25 mg hop extract daily was observed on joint swelling. In conclusion, this standardized CO₂ extract of Humulus lupulus could be a useful agent for intervention strategies targeting inflammatory disorders and/or inflammatory pain.

Key words

Humulus lupulus - hops - PGE₂ - cyclooxygenase - COX-1 - COX-2 - whole blood assay

References

• 1 Holtzman M J, Turk J, Shornick L P. Identification of a pharmacologically distinct prostaglandin H synthase in cultured epithelial cells.  J Biol Chem. 1992;  267 21 438-45
• 2 Hla T, Neilson K. Human cyclooxygenase-2 cDNA.  Proc Natl Acad Sci USA. 1992;  89 7384-8
• 3 Chandrasekharan N V, Dai H, Roos K L, Evanson N K, Tomsik J, Elton T S. et al . COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression.  Proc Natl Acad Sci USA. 2002;  99 13 926-31
• 4 Taniura S, Kamitani H, Watanabe T, Eling T E. Transcriptional regulation of cyclooxygenase-1 by histone deacetylase inhibitors in normal human astrocyte cells.  J Biol Chem. 2002;  277 16 823-30
• 5 Smith C J, Morrow J D, Roberts LJ 2 nd, Marnett L J. Induction of prostaglandin endoperoxide synthase-1 (COX-1) in a human promonocytic cell line by treatment with the differentiating agent TPA.  Adv Exp Med Biol. 1997;  400A 99-106
• 6 Doroudi R, Gan L M, Sjogren L S, Jern S. Intraluminal pressure modulates eicosanoid enzyme expression in vascular endothelium of intact human conduit vessels at physiological levels of shear stress.  J Hypertens. 2002;  20 63-70
• 7 Martel-Pelletier J, Pelletier J P, Fahmi H. Cyclooxygenase-2 and prostaglandins in articular tissues.  Semin Arthritis Rheum. 2003;  33 155-67
• 8 Cryer B, Kimmey M B. Gastrointestinal side effects of nonsteroidal anti-inflammatory drugs.  Am J Med. 1998;  105 20S-30S
• 9 Vane J R. The fight against rheumatism: from willow bark to COX-1 sparing drugs.  J Physiol Pharmacol. 2000;  51 573-86
• 10 Flower R J. The development of COX2 inhibitors.  Nat Rev Drug Discov. 2003;  2 179-91
• 11 Duke J A, Wain K K. Medicinal plants of the world.  In: Computer index with more than 85,000 entries 3. 1981
• 12 Moerman D E. Geraniums for the Iroquois: a field guide to American Indian medicinal plants. Michigan, Algonac; 1982
• 13 Yamamoto K, Wang J, Yamamoto S, Tobe H. Suppression of cyclooxygenase-2 gene transcription by humulone.  Adv Exp Med Biol. 2002;  507 73-7
• 14 Yamamoto K, Wang J, Yamamoto S, Tobe H. Suppression of cyclooxygenase-2 gene transcription by humulone of beer hop extract studied with reference to glucocorticoid.  FEBS Lett. 2000;  465 103-6
• 15 Hougee S, Sanders A, Faber J, Graus Y MF, van den Berg W B, Garssen J. et al . Decreased pro-inflammatory cytokine production by LPS-stimulated PBMC upon in vitro incubation with the flavonoids apigenin, luteolin or chrysin, due to selective elimination of monocytes/macrophages.  Biochem Pharmacol. 2005;  69 241-8
• 16 Warner T D, Giuliano F, Vojnovic I, Bukasa A, Mitchell J A, Vane J R. Nonsteroid drug selectivities for cyclooxygenase-1 rather than cyclooxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis.  Proc Natl Acad Sci USA. 1999;  96 7563-8
• 17 Verschure P, van Marle J, Joosten L, van den Berg W. Chondrocyte IGF-1 receptor expression and responsiveness to IGF-1 stimulation in mouse articular cartilage during various phases of experimentally induced arthritis.  Ann Rheum Dis. 1995;  54 645-53
• 18 Dingle J T. The effects of NSAID on the matrix of human articular cartilages.  Z Rheumatol. 1999;  58 125-9
• 19 de Vries B J, van den Berg W B, Vitters E, van de Putte L B. Quantitation of glycosaminoglycan metabolism in anatomically intact articular cartilage of the mouse patella: in vitro and in vivo studies with ³⁵S-sulfate, ³H-glucosamine, and ³H-acetate.  Rheumatol Int. 1986;  6 273-81
• 20 Lemay M, Murray M A, Davies A, Roh-Schmidt H, Randolph R K. In vitro and ex vivo cyclooxygenase inhibition by a hops extract.  Asia Pac J Clin Nutr. 2004;  13 S110
• 21 de Vries B J, van den Berg W B, Vitters E, van de Putte L B. Effects of NSAIDs on the metabolism of sulphated glycosaminoglycans in healthy and (post) arthritic murine articular cartilage.  Drugs. 1988;  35 Suppl 1 24-32
• 22 Hugenberg S T, Brandt K D, Cole C A. Effect of sodium salicylate, aspirin, and ibuprofen on enzymes required by the chondrocyte for synthesis of chondroitin sulfate.  J Rheumatol. 1993;  20 2128-33
• 23 Dingle J T. Cartilage maintenance in osteoarthritis: interaction of cytokines, NSAID and prostaglandins in articular cartilage damage and repair.  J Rheumatol. 1991;  28 (Suppl) 30-7
• 24 Brandt K D. Nonsteroidal anti-inflammatory drugs and articular cartilage.  J Rheumatol. 1987;  14 Spec No 132-3
• 25 Wang B, Yao Y Y, Chen M Z. Effects of indomethacin on joint damage in rat and rabbit.  Zhongguo Yao Li Xue Bao. 1998;  19 70-3
• 26 El Hajjaji H, Marcelis A, Devogelaer J P, Manicourt D H. Celecoxib has a positive effect on the overall metabolism of hyaluronan and proteoglycans in human osteoarthritic cartilage.  J Rheumatol. 2003;  30 2444-51
• 27 Mastbergen S C, Lafeber F P, Bijlsma J W. Selective COX-2 inhibition prevents proinflammatory cytokine-induced cartilage damage.  Rheumatology (Oxford). 2002;  41 801-8
• 28 Blot L, Marcelis A, Devogelaer J P, Manicourt D H. Effects of diclofenac, aceclofenac and meloxicam on the metabolism of proteoglycans and hyaluronan in osteoarthritic human cartilage.  Br J Pharmacol. 2000;  131 1413-21
• 29 Mastbergen S C, Bijlsma J W, Lafeber F P. Selective COX-2 inhibition is favorable to human early and late-stage osteoarthritic cartilage: a human in vitro study.  Osteoarthritis Cartilage. 2005;  13 519-26
• 30 Francischi J N, Chaves C T, Moura A C, Lima A S, Rocha O A, Ferreira-Alves D L. et al . Selective inhibitors of cyclo-oxygenase-2 (COX-2) induce hypoalgesia in a rat paw model of inflammation.  Br J Pharmacol. 2002;  137 837-44
• 31 Feltenstein M W, Schuhly W, Warnick J E, Fischer N H, Sufka K J. Anti-inflammatory and anti-hyperalgesic effects of sesquiterpene lactones from Magnolia and Bear’s foot.  Pharmacol Biochem Behav. 2004;  79 299-302